Source author record

Wynne Hsu

Wynne Hsu appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

3works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Towards Bridging the gap between Empirical and Certified Robustness against Adversarial Examples

The current state-of-the-art defense methods against adversarial examples typically focus on improving either empirical or certified robustness. Among them, adversarially trained (AT) models produce empirical state-of-the-art defense against adversarial examples without providing any robustness guarantees for large classifiers or higher-dimensional inputs. In contrast, existing randomized smoothing based models achieve state-of-the-art certified robustness while significantly degrading the empirical robustness against adversarial examples. In this paper, we propose a novel method, called \emph{Certification through Adaptation}, that transforms an AT model into a randomized smoothing classifier during inference to provide certified robustness for $\ell_2$ norm without affecting their empirical robustness against adversarial attacks. We also propose \emph{Auto-Noise} technique that efficiently approximates the appropriate noise levels to flexibly certify the test examples using randomized smoothing technique. Our proposed \emph{Certification through Adaptation} with \emph{Auto-Noise} technique achieves an \textit{average certified radius (ACR) scores} up to $1.102$ and $1.148$ respectively for CIFAR-10 and ImageNet datasets using AT models without affecting their empirical robustness or benign accuracy. Therefore, our paper is a step towards bridging the gap between the empirical and certified robustness against adversarial examples by achieving both using the same classifier.

preprint2021arXiv

Towards Maximizing the Representation Gap between In-Domain & Out-of-Distribution Examples

Among existing uncertainty estimation approaches, Dirichlet Prior Network (DPN) distinctly models different predictive uncertainty types. However, for in-domain examples with high data uncertainties among multiple classes, even a DPN model often produces indistinguishable representations from the out-of-distribution (OOD) examples, compromising their OOD detection performance. We address this shortcoming by proposing a novel loss function for DPN to maximize the \textit{representation gap} between in-domain and OOD examples. Experimental results demonstrate that our proposed approach consistently improves OOD detection performance.

preprint2020arXiv

PREMIER: Personalized REcommendation for Medical prescrIptions from Electronic Records

The broad adoption of Electronic Health Records (EHR) has led to vast amounts of data being accumulated on a patient's history, diagnosis, prescriptions, and lab tests. Advances in recommender technologies have the potential to utilize this information to help doctors personalize the prescribed medications. In this work, we design a two-stage attention-based personalized medication recommender system called PREMIER which incorporates information from the EHR to suggest a set of medications. Our system takes into account the interactions among drugs in order to minimize the adverse effects for the patient. We utilize the various attention weights in the system to compute the contributions from the information sources for the recommended medications. Experiment results on MIMIC-III and a proprietary outpatient dataset show that PREMIER outperforms state-of-the-art medication recommendation systems while achieving the best tradeoff between accuracy and drug-drug interaction. Two case studies are also presented demonstrating that the justifications provided by PREMIER are appropriate and aligned to clinical practices.